DaVita Inc, founded in 1994 and headquartered in Denver, Colorado, is a leading provider of kidney care and dialysis services. The company operates more than 2,700 outpatient dialysis centers in the United States and serves approximately 200,000 patients annually, focusing on improving the quality of life for individuals with chronic kidney failure.
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| DVA 3.75% 2031-02-15 USDDaVita Inc | United States | 2031-02-15 | 3.750 | 5.55 |
| DVA 3.75% 2031-02-15 USDDaVita Inc | United States | 2031-02-15 | 3.750 | 5.65 |
| DVA 4.63% 2030-06-01 USDDaVita Inc | United States | 2030-06-01 | 4.625 | 5.48 |
| DVA 4.63% 2030-06-01 USDDaVita Inc | United States | 2030-06-01 | 4.625 | 5.37 |
| DVA 4.63% 2030-06-01 USDDaVita Inc | United States | 2030-06-01 | 4.625 | — |
| DVA 6.88% 2032-09-01 USDDaVita Inc | United States | 2032-09-01 | 6.875 | 5.90 |
| DVA 6.88% 2032-09-01 USDDaVita Inc | United States | 2032-09-01 | 6.875 | 6.18 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
DaVita began issuing bonds in the early 2000s to support its growth and acquisitions, with noteworthy issuances including a $1 billion bond in 2014 to finance the acquisition of HealthCare Partners. As of late 2023, DaVita's bond yields remain competitive compared to the healthcare services industry, reflecting investor confidence in its financial stability. Additionally, the company has issued bonds with unique features such as call options, allowing for greater flexibility in capital management amid changing market conditions.